vs
Side-by-side financial comparison of Honest Company, Inc. (HNST) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Honest Company, Inc. is the larger business by last-quarter revenue ($78.1M vs $39.6M, roughly 2.0× SBC Medical Group Holdings Inc). On growth, SBC Medical Group Holdings Inc posted the faster year-over-year revenue change (-10.9% vs -19.7%). Over the past eight quarters, Honest Company, Inc.'s revenue compounded faster (-8.4% CAGR vs -15.0%).
The Honest Company, Inc. is an American digital-first consumer goods company, based in Los Angeles and founded by actress Jessica Alba, Christopher Gavigan, and Brian Lee. The company had $319 million in 2021 sales, and was valued at roughly $550 million as of February 2022. Carla Vernón, Chief Executive Officer, is one of the first Afro-Latina CEOs of a U.S. publicly traded company. The Honest Company has raised multiple rounds of venture capital, and went public via an initial public offeri...
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
HNST vs SBC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $78.1M | $39.6M |
| Net Profit | — | $14.2M |
| Gross Margin | 42.6% | 73.1% |
| Operating Margin | 56.6% | 32.5% |
| Net Margin | — | 35.9% |
| Revenue YoY | -19.7% | -10.9% |
| Net Profit YoY | — | 117.2% |
| EPS (diluted) | $0.00 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $78.1M | — | ||
| Q4 25 | $88.0M | $39.6M | ||
| Q3 25 | $92.6M | $43.4M | ||
| Q2 25 | $93.5M | $43.4M | ||
| Q1 25 | $97.3M | $47.3M | ||
| Q4 24 | $99.8M | $44.4M | ||
| Q3 24 | $99.2M | $53.1M | ||
| Q2 24 | $93.0M | $53.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-23.6M | $14.2M | ||
| Q3 25 | $758.0K | $12.8M | ||
| Q2 25 | $3.9M | $2.5M | ||
| Q1 25 | $3.3M | $21.5M | ||
| Q4 24 | $-809.0K | $6.5M | ||
| Q3 24 | $165.0K | $2.8M | ||
| Q2 24 | $-4.1M | $18.5M |
| Q1 26 | 42.6% | — | ||
| Q4 25 | 15.7% | 73.1% | ||
| Q3 25 | 37.3% | 70.6% | ||
| Q2 25 | 40.4% | 69.2% | ||
| Q1 25 | 38.7% | 79.7% | ||
| Q4 24 | 38.8% | 76.3% | ||
| Q3 24 | 38.7% | 81.5% | ||
| Q2 24 | 38.3% | 74.2% |
| Q1 26 | 56.6% | — | ||
| Q4 25 | -27.5% | 32.5% | ||
| Q3 25 | 0.3% | 36.6% | ||
| Q2 25 | 3.1% | 33.6% | ||
| Q1 25 | 2.6% | 51.1% | ||
| Q4 24 | -1.0% | 10.6% | ||
| Q3 24 | 0.1% | 26.1% | ||
| Q2 24 | -4.3% | 51.4% |
| Q1 26 | — | — | ||
| Q4 25 | -26.8% | 35.9% | ||
| Q3 25 | 0.8% | 29.6% | ||
| Q2 25 | 4.1% | 5.7% | ||
| Q1 25 | 3.3% | 45.4% | ||
| Q4 24 | -0.8% | 14.7% | ||
| Q3 24 | 0.2% | 5.3% | ||
| Q2 24 | -4.4% | 34.8% |
| Q1 26 | $0.00 | — | ||
| Q4 25 | $-0.21 | $0.15 | ||
| Q3 25 | $0.01 | $0.12 | ||
| Q2 25 | $0.03 | $0.02 | ||
| Q1 25 | $0.03 | $0.21 | ||
| Q4 24 | $-0.01 | $0.05 | ||
| Q3 24 | $0.00 | $0.03 | ||
| Q2 24 | $-0.04 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.4M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $169.1M | $248.3M |
| Total Assets | $214.9M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $90.4M | — | ||
| Q4 25 | $89.6M | $164.1M | ||
| Q3 25 | $71.5M | $127.4M | ||
| Q2 25 | $72.1M | $152.7M | ||
| Q1 25 | $72.8M | $132.1M | ||
| Q4 24 | $75.4M | $125.0M | ||
| Q3 24 | $53.4M | $137.4M | ||
| Q2 24 | $36.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — |
| Q1 26 | $169.1M | — | ||
| Q4 25 | $169.7M | $248.3M | ||
| Q3 25 | $190.2M | $248.0M | ||
| Q2 25 | $187.0M | $244.6M | ||
| Q1 25 | $180.4M | $226.4M | ||
| Q4 24 | $174.3M | $195.1M | ||
| Q3 24 | $133.9M | $205.0M | ||
| Q2 24 | $129.7M | $8.8M |
| Q1 26 | $214.9M | — | ||
| Q4 25 | $225.4M | $380.4M | ||
| Q3 25 | $241.5M | $321.4M | ||
| Q2 25 | $249.0M | $315.3M | ||
| Q1 25 | $265.3M | $284.6M | ||
| Q4 24 | $247.4M | $266.1M | ||
| Q3 24 | $209.2M | $296.5M | ||
| Q2 24 | $200.2M | $19.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | 0.6% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $19.3M | $52.0M | ||
| Q3 25 | $-504.0K | $-20.9M | ||
| Q2 25 | $-745.0K | $-8.3M | ||
| Q1 25 | $-2.9M | $1.9M | ||
| Q4 24 | $-16.8M | $-7.3M | ||
| Q3 24 | $15.1M | $5.0M | ||
| Q2 24 | $2.9M | $19.2M |
| Q1 26 | — | — | ||
| Q4 25 | $18.1M | $51.2M | ||
| Q3 25 | $-624.0K | $-20.9M | ||
| Q2 25 | $-826.0K | $-8.6M | ||
| Q1 25 | $-3.0M | $1.7M | ||
| Q4 24 | $-17.2M | $-7.9M | ||
| Q3 24 | $15.0M | $4.6M | ||
| Q2 24 | $2.9M | $18.3M |
| Q1 26 | — | — | ||
| Q4 25 | 20.5% | 129.3% | ||
| Q3 25 | -0.7% | -48.3% | ||
| Q2 25 | -0.9% | -19.9% | ||
| Q1 25 | -3.1% | 3.5% | ||
| Q4 24 | -17.2% | -17.8% | ||
| Q3 24 | 15.1% | 8.7% | ||
| Q2 24 | 3.1% | 34.5% |
| Q1 26 | 0.6% | — | ||
| Q4 25 | 1.4% | 2.0% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.1% | 0.7% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 0.3% | 1.3% | ||
| Q3 24 | 0.1% | 0.8% | ||
| Q2 24 | 0.0% | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.66× | ||
| Q3 25 | -0.66× | -1.63× | ||
| Q2 25 | -0.19× | -3.39× | ||
| Q1 25 | -0.90× | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 91.42× | 1.77× | ||
| Q2 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HNST
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
